Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.2 Billion CNY | 1.54% |
| 2022 | 4.14 Billion CNY | 21.9% |
| 2021 | 3.39 Billion CNY | -14.88% |
| 2020 | 3.99 Billion CNY | -18.21% |
| 2019 | 4.87 Billion CNY | 20.48% |
| 2018 | 4.04 Billion CNY | 36.65% |
| 2017 | 2.96 Billion CNY | 24.37% |
| 2016 | 2.38 Billion CNY | 14.15% |
| 2015 | 2.08 Billion CNY | -21.87% |
| 2014 | 2.67 Billion CNY | 27.13% |
| 2013 | 2.1 Billion CNY | 17.79% |
| 2012 | 1.78 Billion CNY | 21.1% |
| 2011 | 1.47 Billion CNY | 29.62% |
| 2010 | 1.13 Billion CNY | 38.82% |
| 2009 | 818.78 Million CNY | 44.9% |
| 2008 | 565.08 Million CNY | 31.78% |
| 2007 | 428.81 Million CNY | 75.16% |
| 2006 | 244.8 Million CNY | -8.61% |
| 2005 | 267.87 Million CNY | 27.31% |
| 2004 | 210.41 Million CNY | 61.76% |
| 2003 | 130.08 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.03 Billion CNY | -8.06% |
| 2024 Q2 | 1.03 Billion CNY | 0.0% |
| 2023 Q4 | 1.13 Billion CNY | 0.0% |
| 2023 FY | 4.2 Billion CNY | 1.54% |
| 2023 Q1 | 971.68 Million CNY | -7.04% |
| 2023 Q2 | 971.68 Million CNY | 0.0% |
| 2023 Q3 | 1.13 Billion CNY | 16.34% |
| 2022 Q2 | 1.02 Billion CNY | 0.0% |
| 2022 Q3 | 1.04 Billion CNY | 1.97% |
| 2022 Q4 | 1.04 Billion CNY | 0.0% |
| 2022 FY | 4.14 Billion CNY | 21.9% |
| 2022 Q1 | 1.02 Billion CNY | 42.07% |
| 2021 Q2 | 976.84 Million CNY | 0.0% |
| 2021 Q3 | 721.52 Million CNY | -26.14% |
| 2021 FY | 3.39 Billion CNY | -14.88% |
| 2021 Q1 | 976.84 Million CNY | 8.98% |
| 2021 Q4 | 721.52 Million CNY | 0.0% |
| 2020 Q3 | 896.37 Million CNY | -18.43% |
| 2020 FY | 3.99 Billion CNY | -18.21% |
| 2020 Q2 | 1.09 Billion CNY | 0.0% |
| 2020 Q1 | 1.09 Billion CNY | -10.18% |
| 2020 Q4 | 896.37 Million CNY | 0.0% |
| 2019 Q3 | 1.22 Billion CNY | 0.61% |
| 2019 FY | 4.87 Billion CNY | 20.48% |
| 2019 Q4 | 1.22 Billion CNY | 0.0% |
| 2019 Q1 | 1.21 Billion CNY | 6.07% |
| 2019 Q2 | 1.21 Billion CNY | 0.0% |
| 2018 Q1 | 878.24 Million CNY | 14.28% |
| 2018 Q3 | 1.14 Billion CNY | 30.54% |
| 2018 Q4 | 1.14 Billion CNY | 0.0% |
| 2018 FY | 4.04 Billion CNY | 36.65% |
| 2018 Q2 | 878.24 Million CNY | 0.0% |
| 2017 Q4 | 768.49 Million CNY | 0.0% |
| 2017 Q3 | 768.49 Million CNY | 7.75% |
| 2017 Q2 | 713.18 Million CNY | 0.0% |
| 2017 Q1 | 713.18 Million CNY | 26.93% |
| 2017 FY | 2.96 Billion CNY | 24.37% |
| 2016 Q3 | 561.88 Million CNY | -10.74% |
| 2016 FY | 2.38 Billion CNY | 14.15% |
| 2016 Q4 | 561.88 Million CNY | 0.0% |
| 2016 Q2 | 629.48 Million CNY | 0.0% |
| 2016 Q1 | 629.48 Million CNY | 32.95% |
| 2015 Q2 | 570.21 Million CNY | 0.0% |
| 2015 Q3 | 473.49 Million CNY | -16.96% |
| 2015 Q4 | 473.49 Million CNY | 0.0% |
| 2015 Q1 | 570.21 Million CNY | 49.2% |
| 2015 FY | 2.08 Billion CNY | -21.87% |
| 2014 Q2 | 648.55 Million CNY | 0.0% |
| 2014 Q4 | 382.18 Million CNY | 0.0% |
| 2014 FY | 2.67 Billion CNY | 27.13% |
| 2014 Q1 | 648.55 Million CNY | 17.45% |
| 2014 Q3 | 382.18 Million CNY | -41.07% |
| 2013 Q1 | 498.61 Million CNY | 0.0% |
| 2013 Q3 | 552.18 Million CNY | 10.74% |
| 2013 FY | 2.1 Billion CNY | 17.79% |
| 2013 Q4 | 552.18 Million CNY | 0.0% |
| 2013 Q2 | 498.61 Million CNY | 0.0% |
| 2012 FY | 1.78 Billion CNY | 21.1% |
| 2012 Q2 | 423.12 Million CNY | -4.12% |
| 2012 Q1 | 441.29 Million CNY | 7.5% |
| 2011 Q2 | 361.8 Million CNY | 16.0% |
| 2011 Q1 | 311.9 Million CNY | 27.12% |
| 2011 FY | 1.47 Billion CNY | 29.62% |
| 2011 Q4 | 410.5 Million CNY | 5.51% |
| 2011 Q3 | 389.06 Million CNY | 7.54% |
| 2010 FY | 1.13 Billion CNY | 38.82% |
| 2010 Q1 | 267 Million CNY | 14.81% |
| 2010 Q3 | 329.6 Million CNY | 11.85% |
| 2010 Q4 | 245.35 Million CNY | -25.56% |
| 2010 Q2 | 294.68 Million CNY | 10.37% |
| 2009 Q1 | 158.39 Million CNY | 0.0% |
| 2009 Q2 | 208.36 Million CNY | 31.55% |
| 2009 Q4 | 232.56 Million CNY | 5.97% |
| 2009 FY | 818.78 Million CNY | 44.9% |
| 2009 Q3 | 219.45 Million CNY | 5.32% |
| 2008 FY | 565.08 Million CNY | 31.78% |
| 2007 FY | 428.81 Million CNY | 75.16% |
| 2006 FY | 244.8 Million CNY | -8.61% |
| 2005 FY | 267.87 Million CNY | 27.31% |
| 2004 FY | 210.41 Million CNY | 61.76% |
| 2003 FY | 130.08 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 24.39 Billion HKD | 82.768% |